332 related articles for article (PubMed ID: 23803674)
1. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
[TBL] [Abstract][Full Text] [Related]
2. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
3. Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles.
Sartori MT; Della Puppa A; Ballin A; Saggiorato G; Bernardi D; Padoan A; Scienza R; d'Avella D; Cella G
J Neurooncol; 2011 Aug; 104(1):225-31. PubMed ID: 21104297
[TBL] [Abstract][Full Text] [Related]
4. Circulating microparticles and risk of venous thromboembolism.
Bucciarelli P; Martinelli I; Artoni A; Passamonti SM; Previtali E; Merati G; Tripodi A; Mannucci PM
Thromb Res; 2012 May; 129(5):591-7. PubMed ID: 21908018
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
[TBL] [Abstract][Full Text] [Related]
6. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
[TBL] [Abstract][Full Text] [Related]
7. Circulating procoagulant microparticles in cancer patients.
Thaler J; Ay C; Weinstabl H; Dunkler D; Simanek R; Vormittag R; Freyssinet JM; Zielinski C; Pabinger I
Ann Hematol; 2011 Apr; 90(4):447-53. PubMed ID: 20981426
[TBL] [Abstract][Full Text] [Related]
8. Circulating microparticles in carriers of prothrombin G20210A mutation.
Campello E; Spiezia L; Radu CM; Gavasso S; Zerbinati P; Woodhams B; Simioni P
Thromb Haemost; 2014 Sep; 112(3):432-7. PubMed ID: 24816676
[TBL] [Abstract][Full Text] [Related]
9. Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S.
Campello E; Spiezia L; Radu CM; Bulato C; Gavasso S; Tormene D; Woodhams B; Dalla Valle F; Simioni P
Thromb Haemost; 2016 Jan; 115(1):81-8. PubMed ID: 26354831
[TBL] [Abstract][Full Text] [Related]
10. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
12. High concentration of the plasma microparticles for venous thromboembolism associated with lung cancer.
Wang M; Huang X; Zhu M; Zhang S; Zhang Y
Clin Respir J; 2020 May; 14(5):481-487. PubMed ID: 32031323
[TBL] [Abstract][Full Text] [Related]
13. Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year.
Thaler J; Koppensteiner R; Pabinger I; Ay C; Gremmel T
Thromb Res; 2014 Nov; 134(5):1093-6. PubMed ID: 25262106
[TBL] [Abstract][Full Text] [Related]
14. Annexin V
Chen Y; Liu J; Su Y; Zhao H; Zhao Y; Wen M; Lu S; Cao X; Zhang W; Liu L; Wu J
Clin Chim Acta; 2022 Nov; 536():169-179. PubMed ID: 36191610
[TBL] [Abstract][Full Text] [Related]
15. Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation.
Thaler J; Koder S; Kornek G; Pabinger I; Ay C
Transl Res; 2014 Feb; 163(2):145-50. PubMed ID: 23973167
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor exposing microparticles in inflammatory bowel disease.
Palkovits J; Novacek G; Kollars M; Hron G; Osterode W; Quehenberger P; Kyrle PA; Vogelsang H; Reinisch W; Papay P; Weltermann A
J Crohns Colitis; 2013 Apr; 7(3):222-9. PubMed ID: 22705067
[TBL] [Abstract][Full Text] [Related]
17. Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity.
Boles JC; Williams JC; Hollingsworth RM; Wang JG; Glover SL; Owens AP; Barcel DA; Kasthuri RS; Key NS; Mackman N
Thromb Res; 2012 Feb; 129(2):197-203. PubMed ID: 21762960
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer.
Date K; Ettelaie C; Maraveyas A
J Thromb Haemost; 2017 Dec; 15(12):2289-2299. PubMed ID: 29028284
[TBL] [Abstract][Full Text] [Related]
19. Involvement of microparticles in diabetic vascular complications.
Tsimerman G; Roguin A; Bachar A; Melamed E; Brenner B; Aharon A
Thromb Haemost; 2011 Aug; 106(2):310-21. PubMed ID: 21713319
[TBL] [Abstract][Full Text] [Related]
20. Serum GFAP is a diagnostic marker for glioblastoma multiforme.
Jung CS; Foerch C; Schänzer A; Heck A; Plate KH; Seifert V; Steinmetz H; Raabe A; Sitzer M
Brain; 2007 Dec; 130(Pt 12):3336-41. PubMed ID: 17998256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
